[go: up one dir, main page]

AU1346000A - Oxazolidinones useful as alpha 1a adrenoceptor antagonists - Google Patents

Oxazolidinones useful as alpha 1a adrenoceptor antagonists

Info

Publication number
AU1346000A
AU1346000A AU13460/00A AU1346000A AU1346000A AU 1346000 A AU1346000 A AU 1346000A AU 13460/00 A AU13460/00 A AU 13460/00A AU 1346000 A AU1346000 A AU 1346000A AU 1346000 A AU1346000 A AU 1346000A
Authority
AU
Australia
Prior art keywords
alpha
adrenoceptor antagonists
oxazolidinones useful
oxazolidinones
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13460/00A
Inventor
Mark G. Bock
Jennie B. Nerenberg
Michael A. Patane
Harold G. Selnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU1346000A publication Critical patent/AU1346000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU13460/00A 1998-11-10 1999-11-09 Oxazolidinones useful as alpha 1a adrenoceptor antagonists Abandoned AU1346000A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10783898P 1998-11-10 1998-11-10
US60107838 1998-11-10
US19050598A 1998-11-12 1998-11-12
US09190505 1998-11-12
PCT/US1999/026438 WO2000027817A1 (en) 1998-11-10 1999-11-09 Oxazolidinones useful as alpha 1a adrenoceptor antagonists

Publications (1)

Publication Number Publication Date
AU1346000A true AU1346000A (en) 2000-05-29

Family

ID=26805219

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13460/00A Abandoned AU1346000A (en) 1998-11-10 1999-11-09 Oxazolidinones useful as alpha 1a adrenoceptor antagonists

Country Status (2)

Country Link
AU (1) AU1346000A (en)
WO (1) WO2000027817A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999048530A1 (en) * 1998-03-23 1999-09-30 Merck & Co., Inc. Combination therapy for the treatment of benign prostatic hyperplasia

Also Published As

Publication number Publication date
WO2000027817A1 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
AU4423499A (en) Novel analgesic agents
AU8441798A (en) Tricyclically substituted oxazolidinones
AU2616199A (en) Novel bicyclene-substituted oxazolidinones
AU5227999A (en) Substituted oxazolines as antiproliferative agents
AU4318000A (en) Agarobiose-containing composition
AU4431000A (en) Novel use
HUP9904215A3 (en) 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
AU5970699A (en) Use
AU1290501A (en) Composition
AU3472600A (en) Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists
IL130094A0 (en) 2-Imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
IL148275A0 (en) Substituted 3-phenyl-5-alkoxy-1, 3, 4-oxdiazol-2-ones- and their use as lipase inhibitors
AU2656799A (en) Metal-thiols as imminomodulating agents
AU1406001A (en) Auto-adhesive composition
AU1345600A (en) Pyrimidinedione derivatives useful as alpha 1a adrenoceptor antagonists
AU1345900A (en) Oxazolidinones useful as alpha 1a adrenoceptor antagonists
AU2031701A (en) Toothbrush device
AU1346000A (en) Oxazolidinones useful as alpha 1a adrenoceptor antagonists
AU1345800A (en) Oxazolidinones useful as alpha 1a adrenoceptor antagonists
GB9810180D0 (en) Novel formulation
AU5433898A (en) 2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists
AU6994600A (en) Substituted benzoxazoles
HUP9904660A3 (en) 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
AU2594399A (en) Components with releasable leads
AU4322300A (en) Divided buffer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase